Journal of Neuroimmunology
Volume 227, Issue 1 , Pages 195-201 , 8 October 2010

The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus

  • Gehan A. Mostafa

      Affiliations

    • Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    • Corresponding Author InformationCorresponding author. 9 Ahmed El-Samman Street off Makram Ebaid, Nasr City, Cairo, Egypt. Tel.: +20 103512877, +20 2 22713217; fax: +20 2 4820237.
    • ,
  • Dalia H. Ibrahim

      Affiliations

    • Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    • ,
  • Abeer A. Shehab

      Affiliations

    • Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
    • ,
  • Azza K. Mohammed

      Affiliations

    • Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Received 3 April 2010 ,Revised 15 June 2010 ,Accepted 20 July 2010.

References 

  1. Abdel-Nasser AM, Ghaleb RM, Mahmoud JA, Khairy W, Mahmoud RM. Association of anti-ribosomal P antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus. Clin. Rheumatol. 2008;27(11):1377–1385
  2. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature . The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42(4):599–608Agmon-Levin N, Gilburd B, Kivity S, Katz BS, Flitman-Katzevman I, Shoenfeld N, et al. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays. Isr. Med. Assoc. J. 2009;11(7):403–406
  3. Ariga T, McDonald MP, Yu RK. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease—a review. J. Lipid Res. 2008;49(6):1157–1175
  4. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Committee on Progress Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum. 1992;35(6):630–640
  5. Caponi L, Anzilotti C, Longombardo G, Migliorini P. Antibodies directed against ribosomal P proteins cross-react with phospholipids. Clin. Exp. Immunol. 2007;150(1):140–143
  6. Carbotte RM, Denburg SD, Denburg JA. Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J. Rheumatol. 1995;22(5):863–867
  7. Castellino G, Govoni M, Giacuzzo S, Trotta F. Optimizing clinical monitoring of central nervous system involvement in SLE. Autoimmun. Rev. 2008;7(4):297–304
  8. Colasanti T, Delunardo F, Margutti P, Vacirca D, Piro E, Siracusano A, et al. Antibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus. J. Neuroimmunol. 2009;212(1–2):3–9
  9. Costallat LTL, Oliveira RM, Santiago MB. Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anti-cardiolipin, anti-gangliosides and anti-galactocerebrosides antibodies. Clin. Rheumatol. 1990;9:489–497
  10. Efthimiou P, Blanco M. Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers. Mod. Rheumatol. 2009;19(5):457–468
  11. Galaezzi M, Annunziata P, Sebastiani GD, Bellisai F. Anti-ganglioside M1 IgM antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological and HLA class II gene association. J. Rheumatol. 2000;27(1):135–141
  12. Greenwood DL, Gitlits VM, Alderuccio F, Sentry JW, Toh BH. Auto-antibodies in neuropsychiatric lupus. Autoimmunity. 2002;35(2):79–86
  13. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J. Rheumatol. 2004;31(11):2156–2162
  14. Hanly JG, Su L, Farewell V, McCurdy G, Fougere L, Thompson K. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J. Rheumatol. 2009;36(7):1449–1459
  15. Heinlen LD, McClain MT, Merrill J, Akbarali YW, Edgerton CC, Harley JB, et al Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum. 2007;56(7):2344–2351
  16. Hermosillo-Romo D, Brey RL. Diagnosis and managements of patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Best Pract. Res. Clin. Rheumatol. 2002;16(2):229–244
  17. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725
  18. Kajs-Wyllie MK. Lupus cerebritis: a case study. J. Neurosci. Nurs. 2002;34(4):176–183
  19. Karassa F, Loaunidis JP, Boki K. Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am. J. Med. 2000;109:628–634
  20. Kato T, Hatanaka K. Purification of gangliosides by liquid–liquid partition chromatography. J. Lipid Res. 2008;49(11):2474–2478
  21. Khedr EM, Khedr T, Farweez HM, Abdella G, El Beih EA. Multimodel electroneurophysiological studies of systemic lupus erythematosus. Neuropsychobiology. 2001;43(3):204–212
  22. Martinez X, Tintoré M, Montalbán J, Ordi J, Vilardell M, Codina A. Antibodies against gangliosides in patients with SLE and neurological manifestations. Lupus. 1992;1(5):299–302
  23. Meleka LK, Ismail ME. Arabic Translation of Wechsler Intelligence Scale for Children. 6th edn. Cairo: Egyptian Anglo library; 1999;
  24. Morton DL. Human antiganglioside antibodies: validation of ELISA. Ann. NY Acad. Sci. 2005;1050:229–242
  25. Mostafa GA, Nazif HK, El-Shehawy HH, Abd El Aziz MM, Hassan MA. Antineuronal antibodies and electroneurophysiological studies in pediatric patients with neuropsychiatric systemic lupus erythematosus. Pediatr. Allergy Immunol. 2009;20(2):192–199
  26. Navarrete MG, Brey RL. Neuropsychiatric systemic lupus erythematosus. Curr. Treat. Options Neurol. 2000;2(5):473–485
  27. Nived O, Sturfelt G, Liang MH, De Pablo P. The ACR nomenclature for CNS lupus revisited. Lupus. 2003;12:872–876
  28. Olazarán J, López-Longo J, Cruz I, Bittini A, Carreño L. Cognitive dysfunction in systemic lupus erythematosus: prevalence and correlates. Eur. Neurol. 2009;62(1):49–55
  29. Plomp JJ, Willison HJ. Pathophysiological actions of neuropathy-related anti-ganglioside M1 IgM antibodies at the neuromuscular junction. J. Physiol. 2009;587(Pt 16):3979–3999
  30. Ravindranath MH, Muthugounder S, Saravanan TS, Presser N, Morton DL. Human antiganglioside antibodies: validation of ELISA. Ann. NY Acad. Sci. 2005;1050:229–242
  31. Ribeiro CM, Vasconcelos BC, Silva Neto JC, Silva Júnior VA, Figueiredo NG. Histopathological analysis of gangliosides use in peripheral nerve regeneration after axonotmesis in rats. Acta Cir. Bras. 2008;23(4):364–371
  32. Sanna G, Bertolaccini ML, Mathieu A. Central nervous system lupus: a clinical approach to therapy. Lupus. 2003;12(12):935–942
  33. Sany-Choel BAE. The ACR classification of neuropsyohiatric systemic lupus erythematosus: how this helps in diagnosis and treatment. APLAR J. Rheumatol. 2003;6:188–191
  34. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry. 1998;59(Suppl 20):22–33
  35. Sibbitt WL, Brandt JR, Johnson CR, Maldomado ME, Patel SR, Ford CC. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J. Rheumatol. 2002;29(7):1536–1542
  36. Stojanovich L, Zandman-Goddard G, Pavlovich S. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun. Rev. 2007;6(6):421–426
  37. Sugiura Y, Shimma S, Konishi Y, Yamada MK, Setou M. Imaging mass spectrometry technology and application on ganglioside study; visualization of age-dependent accumulation of C20-ganglioside molecular species in the mouse hippocampus. PLoS ONE. 2008;3(9):e3232
  38. Teh LS. Neuropsychiatric systemic lupus erythematosus (NPSLE). CPD Rheumatol. 2003;3(3):77–81
  39. Tzioufas AG, Tzortzakis NG, Panou-Pomonis E, Boki KA, Sakarellos-Daitsiotis M, Sakarellos C, et al. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease. Ann. Rheum. Dis. 2000;59(2):99–104
  40. Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J. Neuroimmunol. 2002;129(1–2):168–177
  41. Watanabe O, Arimura K. Pathomechanism of autoantibody production in neurological disorders. Nippon Rinsho. 2008;66(6):1065–1072
  42. Wechsler D. Wechsler Intelligence Scale for Children. 3rd edn. New York: Psychological Corporation. Harcourt Brace and Company Publishers; 1991;
  43. Yoshida A, Shishido F, Kato K. Evaluation of cerebral perfusion in patients with neuropsychiatric systemic lupus erythematosus using 1231-Imp spect. Ann. Nucl. Med. 2007;21(3):151–158
  44. Yoshio T, Masuyama J, Ikeda M, Tamai K, Hachiya T, Emori T, et al. Quantification of antiribosomal PO protein antibodies by ELISA with recombinant PO fusion protein and their association with central system disease in systemic lupus erythematosus. J. Rheumatol. 1995;22:1681–1687
  45. Zitman FM, Todorov B, Jacobs BC, Verschuuren JJ, Furukawa K, Furukawa K, et al. Neuromuscular synaptic function in mice lacking major subsets of gangliosides. Neuroscience. 2008;156(4):885–897
  46. Zitman FM, Todorov B, Verschuuren JJ, Jacobs BC, Furukawa K, Furukawa K, et al. Neuromuscular synaptic transmission in aged ganglioside-deficient mice. Neurobiol. Aging. 2009;Feb 20 [Epub ahead of print]
  47. Zitman FM, Todorov B, Furukawa K, Furukawa K, Willison HJ, Plomp JJ. Total ganglioside ablation at mouse motor nerve terminals alters neurotransmitter release level. Synapse. 2010;64(4):335–338

PII: S0165-5728(10)00327-9

doi: 10.1016/j.jneuroim.2010.07.014

Journal of Neuroimmunology
Volume 227, Issue 1 , Pages 195-201 , 8 October 2010

Article Tools